Drug utilisation profile in the Italian paediatric population

European Journal of Pediatrics

Volumn 168, Issue 2, 2009, Pages 173-180

  Clavenna, Antonio ^a   Berti, Alessandra ^b   Gualandi, Lucia ^b   Rossi, Elisa ^b   De Rosa, Marisa ^b   Bonati, Maurizio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b CINECA   (Italy)

Author keywords

Child; Drug utilisation; General practice; Italy

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; AZITHROMYCIN; BECLOMETASONE; BETAMETHASONE; BUDESONIDE; CEFACLOR; CEFIXIME; CEPHALOSPORIN; CETIRIZINE; CLARITHROMYCIN; CORTICOSTEROID; FLUNISOLIDE; FLUTICASONE; MACROLIDE; MONTELUKAST; PENICILLIN G; SALBUTAMOL; STEROID;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DRUG COST; DRUG UTILIZATION; FEMALE; HEALTH CARE; HEALTH CENTER; HEALTH PRACTITIONER; HUMAN; MALE; PHARMACY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; AGE FACTORS; AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-ASTHMATIC AGENTS; ANTI-BACTERIAL AGENTS; BECLOMETHASONE; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; FEMALE; HUMANS; INFANT; ITALY; MALE; PEDIATRICS; PRESCRIPTION DRUGS; PRESCRIPTIONS; SEX FACTORS;

EID: 58149103231     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-008-0725-y     Document Type: Article

References (39)

1. L Abi Khaled F Ahmad T Brogan J Fearnley J Graham S MacLeod J McCormick 2003 Prescription medicine use by one million Canadian children Paediatr Child Health 8 Suppl A 6A 56A
2. American Academy of Pediatrics. Subcommittee on Management of Sinusitis and Committee on Quality Improvement 2001 Clinical practice guideline: management of sinusitis Pediatrics 108 798 808
3. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media 2004 Diagnosis and management of acute otitis media Pediatrics 113 1451 1465
4. A Barbato C Panizzolo L Biserna L Cantarutti C Giaquinto F Frati F Marcucci C Monciotti R Testi P di Blasi MC Sturkenboom Pedianet Family Pediatricians Asthma Study Group (F-PASG) 2003 Asthma prevalence and drug prescription in asthmatic children Eur Ann Allergy Clin Immunol 35 47 51
5. C Beimfohr W Maziak E von Mutius HW Hense W Leupold T Hirsch U Keil SK Weiland 2001 The use of anti-asthmatic drugs in children: results of a community-based survey in Germany Pharmacoepidemiol Drug Saf 10 315 321
6. M Bonati 1994 Epidemiologic evaluation of drug use in children J Clin Pharmacol 34 300 305
7. M Bonati A Clavenna F Rocchi 2001 Corticosteroidi in età pediatrica. Marketing e prescrizione Informazioni sui Farmaci 2-3 79 82
8. G Borgnolo G Simon L Francescutti C Lattuada L Zanier 2001 Antibiotic prescription in Italian children: a population-based study in Friuli Venezia Giulia, north-east Italy Acta Paediatr 90 1316 1320
9. T Cazzato C Pandolfini R Campi M Bonati ACP Puglia-Basilicata Working Group 2001 Drug prescribing in out-patient children in Southern Italy Eur J Clin Pharmacol 57 611 616
10. Choonara I, Nunn AJ, Kearns G (eds) (2003) Introduction to paediatric and perinatal drug therapy. Nottingham University Press, Nottingham, UK
11. Cincinnati Children's Hospital Medical Center (2006) Evidence-based care guideline for management of acute bacterial sinusitis in children 1-18 years of age. Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 7 July 2006
12. A Clavenna E Rossi G Berti A Pedrazzi M De Rosa M Bonati ARNO Working Group 2003 Inappropriate use of anti-asthmatic drugs in the Italian paediatric population Eur J Clin Pharmacol 59 565 569
13. A Clavenna M Bonati E Rossi A Berti M De Rosa 2004 Il profilo prescrittivo della popolazione pediatrica italiana nelle cure primarie Ric Prat 20 224 244
14. K Furu S Skurtveit A Langhammer P Nafstad 2007 Use of anti-asthmatic medications as a proxy for prevalence of asthma in children and adolescents in Norway: a nationwide prescription database analysis Eur J Clin Pharmacol 63 693 698
15. C Gagliotti F Morsillo D Resi M Milandri ML Moro 2005 A three-year population-based study of antibiotic treatments for children Acta Paediatr 94 1502 1504
16. C Galassi M De Sario A Biggeri L Bisanti E Chellini G Ciccone MG Petronio S Piffer P Sestini F Rusconi G Viegi F Forastiere 2006 Changes in prevalence of asthma and allergies among children and adolescents in Italy: 1994-2002 Pediatrics 117 34 42
17. The Global Initiative for Asthma (2007) Global Strategy for Asthma Management and Prevention 2007. Home page at: http://www.ginasthma.com
18. DC Goodman P Lozano TA Stukel Ch Chang J Hecht 1999 Has asthma medication use in children become more frequent, more appropriate, or both? Pediatrics 104 187 194
19. GH Hahn A Koch M Melbye K Mølbak 2005 Pattern of drug prescription for children under the age of four years in a population in Greenland Acta Paediatr 94 99 106
20. A Le Grand HV Hogerzeil FM Haaijer-Ruskamp 1999 Intervention research in rational use of drugs: a review Health Policy Plan 14 89 102
21. SM MacLeod 1991 Pharmacoepidemiology: a health imperative J Clin Epidemiol 44 1285 1286
22. H Madsen M Anderson J Halls 2001 Drug prescribing among Danish children: a population-based study Eur J Clin Pharmacol 57 159 165
23. FD Martinez AL Wright LM Taussig CJ Holberg M Halonen WJ Morgan 1995 Asthma and wheezing in the first six years of life. The Group Health Medical Associates N Engl J Med 332 133 138
24. J McIntyre S Conroy A Avery H Corns I Choonara 2000 Unlicensed and off label prescribing of drugs in general practice Arch Dis Child 83 498 501
25. G Moth P Vedsted PO Schiøtz 2007 Identification of asthmatic children using prescription data and diagnosis Eur J Clin Pharmacol 63 605 611
26. BV-L Niclasen 2006 Changes in drug prescription over a decade in an Arctic child population Acta Paediatr 95 1456 1460
27. KF Rabe PA Vermeire JB Soriano WC Maier 2000 Clinical management of asthma in 1999: the asthma insight and the reality in Europe (AIRE) study Eur Respir J 16 802 807
28. D Resi M Milandri ML Moro Emilia Romagna Study Group on the Use of Antibiotics in Children 2003 Antibiotic prescriptions in children J Antimicrob Chemother 52 282 286
29. E Rossi M De Rosa M Bonati A Covezzoli P Busca A Addis G Tognoni USL Gruppo di Lavoro 2001 La prescrizione farmaceutica pediatrica nell'ambito delle cure primarie. Rapporto dalla banca dati ARNO G Ital Farm Clin 15 26 29
30. A Rossignoli A Clavenna M Bonati 2007 Antibiotic prescription and prevalence rate in the outpatient paediatric population: analysis of surveys published during 2000-2005 Eur J Clin Pharmacol 63 1099 1106
31. EJ Sanz 2003 Concordance and children's use of medicines BMJ 327 858 860
32. E Sanz MA Hernández S Ratchina L Stratchounsky MA Peiré M Lapeyre-Mestre B Horen M Kriska H Krajnakova H Momcheva D Encheva I Martínez-Mir V Palop 2004 Drug utilisation in outpatient children. A comparison among Tenerife, Valencia, and Barcelona (Spain), Toulouse (France), Sofia (Bulgaria), Bratislava (Slovakia) and Smolensk (Russia) Eur J Clin Pharmacol 60 127 134
33. E Schirm P van den Berg H Gebben P Sauer L de Jong-van den Berg 2000 Drug use of children in the community assessed through pharmacy dispensing data Br J Clin Pharmacol 50 473 478
34. Scottish Intercollegiate Guidelines Network (SIGN) (1999) Management of sore throat and indication for tonsillectomy. A national clinical guideline. SIGN, Edinburgh, Scotland
35. Scottish Intercollegiate Guidelines Network (SIGN) (2003) Diagnosis and management of childhood otitis media in primary care. A national clinical guideline. SIGN, Edinburgh, Scotland
36. The U.S. Pharmacopeia Drug Utilization Review Advisory Panel 2000 Drug utilization review: mechanisms to improve its effectiveness and broaden its scope J Am Pharm Assoc (Wash) 40 538 545
37. J Townshend S Hails M Mckean 2007 Diagnosis of asthma in children BMJ 335 198 202
38. World Health Organization/Action Programme on Essential Drugs (WHO/DAP) (1995) Operational research projects in DAP: an inventory. WHO/DAP
39. I Wong D Sweis J Cope A Florence 2003 Paediatric medicines research in the UK: how to move forward? Drug Saf 26 529 537